Pacira BioSciences (PCRX) Net Equity Issued and Repurchased (2012)
Pacira BioSciences (PCRX) posted quarterly Net Equity Issued and Repurchased of -$45000.0 for Q2 2012.
Pacira BioSciences (PCRX) Net Equity Issued and Repurchased (2012) Analysis & Trends
Pacira BioSciences' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$45000.0 for Q2 2012.
- In Q2 2012, Net Equity Issued and Repurchased changed N/A year-over-year to -$45000.0; the TTM figure through Dec 2013 stood at -$45000.0 (changed N/A YoY), while the FY2012 annual figure was $62.9 million, up 28.26% from the prior year.
- Net Equity Issued and Repurchased for Q2 2012 stood at -$45000.0.
- The five-year high for Net Equity Issued and Repurchased was -$45000.0 in Q2 2012, with the low at -$45000.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | -45,000.00 |
| Jun 30, 2012 | -45,000.00 |